Details for New Drug Application (NDA): 013295
✉ Email this page to a colleague
NDA 013295 describes CONRAY 43, which is a drug marketed by Liebel-flarsheim and is included in one NDA. Additional details are available on the CONRAY 43 profile page.
The generic ingredient in CONRAY 43 is iothalamate meglumine. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the iothalamate meglumine profile page.
The generic ingredient in CONRAY 43 is iothalamate meglumine. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the iothalamate meglumine profile page.
Summary for 013295
| Tradename: | CONRAY 43 |
| Applicant: | Liebel-flarsheim |
| Ingredient: | iothalamate meglumine |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 013295
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 60% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 43% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
